Ángel García, Departamento de Medicina Interna, Unidad de Cardiología, Pontificia Universidad Javeriana, Hospital Universitario San Ignacio, Bogotá, Colombia
Javier Arango, Asociación Colombiana de Medicina Interna, Bogotá, Colombia
Javier Cabrera, Asociación Colombiana de Gerontología y Geriatría, Bogotá, Colombia
Jaime Melo, Dirección científica, Centros Médicos Keralty, Bogotá; Sociedad Colombiana de Medicina Familiar, Bogotá; Colombia
Harold Miranda, Asociación Colombiana de Medicina Vascular (ACMV), Bogotá; Diagnóstico Vascular S.A.S., Bogotá; Colombia
Katherine Restrepo, Asociación Colombiana de Endocrinología, Diabetes y Metabolismo, Bogotá; Departamento Medicina Interna, Universidad Santiago de Cali, Cali; Departamento Medicina Interna, Universidad Javeriana, Cali; Departamento Medicina Interna, Colsanitas, Cali; Colombia
Marlene I. Vélez, Colegio Nacional de Bacteriología, Bogotá, Colombia
Iván L. Mojica, Dirección científica, SYNLAB, Bogotá, Colombia
Jaime A. Rodríguez, Unidad de Métodos Diagnósticos no Invasivos y Clínica de Insuficiencia Cardíaca y Trasplante, Fundación Cardiovascular de Colombia, Floridablanca; Sociedad Colombiana de Cardiología y Cirugía Cardiovascular, Bogotá. Colombia
Introduction: Alterations in lipid metabolism (dyslipidemia) are the main risk factor for the development of cardiovascular diseases, which are the leading cause of death worldwide and in Colombia. They also generate significant resource consumption within the health system. Therefore, it is necessary to design and implement strategies to ensure early diagnosis and accurate cardiovascular risk assessment, along with standardized guidelines for the measurement, laboratory reporting, and interpretation of lipid profile results. This approach allows for the implementation of preventive measures in patients with dyslipidemia or high cardiovascular risk. Objective: To develop a standardized document emphasizing the importance of lipid measurement in cardiovascular risk assessment, establishing unified criteria for laboratory reports, and defining treatment goals based on risk levels. Method: Through a joint initiative and collaborative effort of several scientific societies and other stakeholders involved in lipid reporting in Colombia, it was proposed to develop a document based on available evidence and the expertise of subject matter experts. This document focuses on the importance of blood lipid measurement for cardiovascular risk assessment and the necessity of obtaining standardized reports and defining treatment targets according to the level of risk. Results: This article is the result of a multi-society effort to provide basic recommendations on the definition of the lipid profile and cardiovascular risk assessment as a necessary step for the prevention, decision-making, treatment, and follow-up of cardiovascular disease in Colombia. The need to unify analysis criteria and guidelines in laboratory lipid profile reports is emphasized to support the patient’s cardiovascular risk assessment. Conclusions: Standardizing lipid profile measurement and reporting is essential to improving cardiovascular risk assessment and optimizing preventive and therapeutic strategies. This consensus represents a key step in aligning national practices with international standards to enhance patient care and reduce the burden of cardiovascular diseases in Colombia.
Keywords: Cardiovascular disease. Lipids. Cardiovascular risk. Laboratory reports. Lipid profile.
